Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 317 (RNA5SP317)

Target: RNA5SP317
Molecular classification: Other (pseudogene), Non-coding RNA pseudogene

Overview

RNA, 5S ribosomal pseudogene 317 (RNA5SP317) is a human, non-coding pseudogene related to the 5S ribosomal RNA family. Pseudogenes such as RNA5SP317 are genomic sequences resembling functional genes but typically lack protein-coding or direct regulatory function due to sequence divergence or disruptive mutations. While the parent molecule (5S ribosomal RNA) is an integral structural component of the large ribosomal subunit involved in protein synthesis and ribosome assembly, pseudogenes like RNA5SP317 are generally considered non-functional. Emerging research suggests that pseudogene expression can influence cancer subtypes and may exert regulatory effects via RNA-mediated pathways, but no direct functional role has been established for RNA5SP317 itself in human biology or disease at present.

Other names: RNA5SP317RN5S317RNA, 5S ribosomal 317

Mechanism of action

None (not a therapeutic target)

Biological functions

None (as a pseudogene, it does not have established direct biological function)Parent molecule (5S ribosomal RNA) is structural, involved in ribosome function and assembly

Disease associations

Other (expression of pseudogenes has been associated with cancer subtypes and may have regulatory roles in tumorigenesis through RNA mechanisms; specific roles for RNA5SP317 are not established)

Safety considerations

None (no safety concerns reported for targeting this pseudogene)

Interacting drugs

None (no drugs are known to interact with RNA5SP317)

Biomarkers

None (not used as a clinical biomarker; some pseudogene expression signatures are being researched in oncology, but RNA5SP317 is not established for such use)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 317 (RNA5SP317).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 317 (RNA5SP317).

Explore the full profile